Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

ClinicalTrials.gov ID: NCT00527735

Public ClinicalTrials.gov record NCT00527735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination With Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Study identification

NCT ID
NCT00527735
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
334 participants

Conditions and interventions

Interventions

  • Ipilimumab Drug
  • Placebo Drug
  • Paclitaxel Drug
  • Carboplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Sep 30, 2009
Completion
Nov 30, 2011
Last update posted
Jul 17, 2018

2008 – 2011

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Birmingham Hematology & Oncology Assoc. Llc Birmingham Alabama 35235
Mayo Clinic Scottsdale Arizona 85259
Acrc/Arizona Clinical Research Center, Inc. Tucson Arizona 85715
Compassionate Cancer Care Medical Group Corona California 92879
Compassionate Cancer Care Medical Group, Inc. Fountain Valley California 92708
The Angeles Clinic & Research Institute, Inc Los Angeles California 90025
Oncology Care Medical Associates Montebello California 90640
Compassionate Cancer Care Medical Group Riverside California 92501
Sharp Clinical Oncology Research San Diego California 92123
M D Anderson Cancer Center- Orlando Orlando Florida 32806
Georgia Cancer Specialists Atlanta Georgia 30341
University Of Chicago Medical Center Chicago Illinois 60637
Local Institution Park Ridge Illinois 60068
Kentucky Cancer Clinic Hazard Kentucky 41701
The John R. Marsh Cancer Center Hagerstown Maryland 21740
Massachusetts General Hospital Boston Massachusetts 02114
The Cancer Center Minneapolis Minnesota 55455
Nevada Cancer Institute Las Vegas Nevada 89135
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Local Institution New York New York 10017
Cmc-Northeast/ Northeast Oncology Associates Concord North Carolina 28025
Gabrail Cancer Center Canton Ohio 44718
Hematology Oncology Consultants, Inc Columbus Ohio 43235
St. Mary Medical Center Langhorne Pennsylvania 19047
Guthrie Clinical Research Sayre Pennsylvania 18840
Santee Hematology/Oncology Sumter South Carolina 29150
Southwest Cancer Treatment And Research Center Lubbock Texas 79415

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00527735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00527735 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →